As a member of the IP Working Party, you have the opportunity to drive forward IT, automated system solutions and standards by sharing experience and knowledge. We discuss the various strategies, IT-related developments and potential new techniques. This WP has three active taskforces:
- Radio Frequency Identification (RFID)
There are currently about 35 active members and 10 active observers in the WPIT. The participation reflects a balanced representation of transfusion medicine/cellular therapy/MPHOfacilities and industry from many countries around the world.
Members of the Executive Committee are:
- Suzanne Butch, Chair and Traceability Task Force Co-Chair
- Goudar Shankar, Vice-Chair
- Paul Ashford, Traceability Task Force Co-Chair
- Open position, Secretary
- Jan-Willem Andriessen, Validation Task Force Chair
- Wayne Bolton, RFID Task Force Chair
- Michael Breard, Past Chair
- Mario Muon, ICCBBA TAG Representative
The WPIT accomplishes its goals through task forces. Currently, there are three task forces: RFID, Traceability, and Validation.
Radio Frequency Identification (RFID)
The RFID Task Force (chairperson: Wayne Bolton, Australia) will determine how this technology can continue to be operationalized into transfusion medicine improving traceability, quality, and safety of the blood supply.
Anticipated actions are:
- Assess the state of the market for the use of RFID in healthcare settings, particularly in transfusion medicine and blood manufacturing/fractionation, documenting what has worked, what has not, and critical success factors
- Evaluate the current ISBT RFID standard and its utility, particularly regarding the use of tag space for information such as genotypes
- Based on the market assessment, seek publication of findings in relevant publication
- Determine next steps
The Traceability Task Force ((Co-Chairs Paul Ashford (Great Britain) and Suzanne Butch (USA)) is creating guidance on traceability that will:
- Define traceability and explain its importance in the field of Transfusion Medicine, cellular therapy and MPHO.
- Provide guidance on what information should be retained for traceability purposes
- Outline the complexities of traceability
- Provide guidance on risk assessment
- Evaluate processes for data migration
- Identify appropriate methods of archiving data whilst retaining traceability
- Provide guidance on what to do when data is lost
- Determine mechanisms to audit traceability reliability and effectiveness
The Validation Task Force (VTF) (chairperson Jan-Willem Andriessen, the Netherlands) has reviewed developments in Good Manufacturing Practice (GMP) compliance for Information technology (IT). While regulations are specific to a region or country, they often contain guidance that is useful for all. The group is nearing completion of the draft guidance document that will then be sent out for comment.
Full members of the WP will have interest in the WP process and must be active or honorary members of ISBT. Observer status may be afforded to non-members of ISBT for a period of up to 2 years.
Observers may attend and participate in the WP meetings, but may not vote.
The WPIT members should have:
- Knowledge of the use of IT in the fields of transfusion and transplantation
- Knowledge of and working in transfusion medicine, cellular therapy, and/or related areas
- Ability to support ISBT WPIT activities on a volunteer basis (free-of-charge) with their employer’s consent and support
- Good communication skills
Interested in joining the WPIT? Complete the below online form.